MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$5,380,063
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
3,957,875
2,767,088
1,124,727
851,537*
General and administrative
1,561,674
1,529,906
1,216,656
1,340,119*
Loss from operations
-5,519,549
-4,296,994
-2,341,383
-2,191,656*
Reimbursement grant income
107,368
66,228
102,425
234,051*
Interest income
275
639
47
842*
Misc other income
-
-
-
0*
Foreign exchange gain
4,295
12,595
-8,758
29,113*
Nonoperating income (expense)
111,938
79,462
93,714
264,006*
Loss before income taxes
-5,407,611
-4,217,532
-
-1,927,650*
Income tax expense
0
800
-
800*
Net loss
-5,407,611
-4,218,332
-2,247,669
-1,928,450*
Exchange differences on translation
27,548
-15,003
-5,315
-416,991*
Net comprehensive loss
-5,380,063
-4,233,335
-2,252,984
-2,345,441
Basic EPS
-0.6
-0.49
-0.28
-0.542
Basic Average Shares
9,007,474
8,541,146
7,972,532
4,330,738
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net comprehensive
loss
-$5,380,063
(-239.47%↓ Y/Y)
Exchange differences on
translation
$27,548
(-83.26%↓ Y/Y)
Net loss
-$5,407,611
(-209.10%↓ Y/Y)
Reimbursement grant income
$107,368
(-41.42%↓ Y/Y)
Foreign exchange gain
$4,295
(114.52%↑ Y/Y)
Interest income
$275
(-51.92%↓ Y/Y)
Loss before income
taxes
-$5,407,611
(-209.10%↓ Y/Y)
Nonoperating income
(expense)
$111,938
(-27.44%↓ Y/Y)
Loss from operations
-$5,519,549
(-189.93%↓ Y/Y)
Research and development
$3,957,875
(321.47%↑ Y/Y)
General and
administrative
$1,561,674
(61.89%↑ Y/Y)
Buy us a coffee
Edesa Biotech, Inc. (EDSA)
Edesa Biotech, Inc. (EDSA)